Showing results (81-90 of 110) with videos related to
Sort By:
Pageof 11
The Annals of Applied Statistics|August 22, 2022
ESTIMATION OF CELL LINEAGE TREES BY MAXIMUM-LIKELIHOOD PHYLOGENETICSJean Feng, William S Dewitt, Aaron McKenna, et al.Journal of the Royal Statistical Society. Series B, Statistical Methodology|December 16, 2014
Strong rules for discarding predictors in lasso-type problemsRobert Tibshirani, Jacob Bien, Jerome Friedman, et al.Biorxiv : the Preprint Server for Biology|December 9, 2024
Thrifty wide-context models of B cell receptor somatic hypermutationKevin Sung, Mackenzie M Johnson, Will Dumm, et al.Elife|August 29, 2025
Thrifty wide-context models of B cell receptor somatic hypermutationKevin Sung, Mackenzie M Johnson, Will Dumm, et al.Survey of Ophthalmology|August 15, 2022
The impact of early exposure to general anesthesia on visual and neurocognitive developmentAudrey M B Wong-Kee-You, Cam Loveridge-Easther, Claudia Mueller, et al.The American Journal of Surgical Pathology|October 15, 2013
Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomasLei Zhao, Tatjana Antic, Daniela Witten, et al.American Journal of Epidemiology|June 25, 2024
Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an applicationMark N Warden, Sonya L Heltshe, Noah Simon, et al.The Annals of Applied Statistics|August 25, 2023
A FLEXIBLE BAYESIAN FRAMEWORK TO ESTIMATE AGE- AND CAUSE-SPECIFIC CHILD MORTALITY OVER TIME FROM SAMPLE REGISTRATION DATAAustin E Schumacher, Tyler H McCormick, Jon Wakefield, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changesJulie M Wu, Andrew H Beck, Lisa L Pate, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2021
A new path for CF clinical trials through the use of historical controlsAmalia S Magaret, Mark Warden, Noah Simon, et al.Pageof 11